home / stock / vrpx / vrpx news

VRPX News and Press, Virpax Pharmaceuticals Inc. From 11/15/23

Stock Information
Company Name: Virpax Pharmaceuticals Inc.
Stock Symbol: VRPX
Market: NASDAQ
Website: virpaxpharma.com
Menu
VRPX VRPX Quote VRPX Short VRPX News VRPX Articles VRPX Message Board
Get VRPX Alerts

News, Short Squeeze, Breakout and More Instantly...
VRPX - Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX) , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indica...
VRPX - Expected US Company Earnings on Wednesday, November 15th, 2023

The RMR Group Inc. (RMR) is expected to report $0.46 for Q4 2023 Indra Sistemas ADR (ISMAY) is expected to report for Q3 2023 Ceapro Inc. (CRPOF) is expected to report for Q2 2024 Tuya Inc. American Depositary Shares each representing one Class A (TUYA) is expected to report $-0.02 fo...

VRPX - Expected US Company Earnings on Wednesday, November 8th, 2023

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

VRPX - Expected earnings - Virpax Pharmaceuticals Inc.

Virpax Pharmaceuticals Inc. (VRPX) is expected to report for Q1 2024
VRPX - Virpax Pharmaceuticals Announces that Envelta(TM) Remains on Track for Trial in Humans Following FDA Review

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indi...

VRPX - Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indi...

VRPX - Gerald Bruce appointed CEO of Novvae Pharmaceuticals

2023-10-02 09:23:59 ET More on Virpax Pharmaceuticals Virpax slips as court rules in favor of Scilex and Sorrento Seeking Alpha’s Quant Rating on Virpax Pharmaceuticals Historical earnings data for Virpax Pharmaceuticals Financial information for Virpa...
VRPX - Gerald W. Bruce Appointed President and CEO of Novvae(TM) Pharmaceuticals

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indicat...

VRPX - Virpax Pharmaceuticals Announces Results of Probudur(TM) Dose Escalation Studies

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indi...

VRPX - Virpax Pharmaceuticals to Present at the LD Micro Main Event XVI

-- Presentation on Tuesday, October 3 rd at 12 PM PT -- Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disord...
Previous 10 Next 10